Meta-analysis of the efficacy and safety of unfractionated heparin versus enoxaparin in conjunction with tenecteplase for ST elevation myocardial infarction: Insights from ASSENT 3 and ASSENT 3 PLUS
Publication
, Conference
Armstrong, PW; Wallentin, L; Goldstein, P; Granger, CB; Bogaerts, K; Danays, T; Van de Werf, F
Published in: CIRCULATION
October 28, 2003
Duke Scholars
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 28, 2003
Volume
108
Issue
17
Start / End Page
580 / 581
Location
ORLANDO, FLORIDA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
76th Annual Scientific Session of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Armstrong, P. W., Wallentin, L., Goldstein, P., Granger, C. B., Bogaerts, K., Danays, T., & Van de Werf, F. (2003). Meta-analysis of the efficacy and safety of unfractionated heparin versus enoxaparin in conjunction with tenecteplase for ST elevation myocardial infarction: Insights from ASSENT 3 and ASSENT 3 PLUS. In CIRCULATION (Vol. 108, pp. 580–581). ORLANDO, FLORIDA: LIPPINCOTT WILLIAMS & WILKINS.
Armstrong, P. W., L. Wallentin, P. Goldstein, C. B. Granger, K. Bogaerts, T. Danays, and F. Van de Werf. “Meta-analysis of the efficacy and safety of unfractionated heparin versus enoxaparin in conjunction with tenecteplase for ST elevation myocardial infarction: Insights from ASSENT 3 and ASSENT 3 PLUS.” In CIRCULATION, 108:580–81. LIPPINCOTT WILLIAMS & WILKINS, 2003.
Armstrong PW, Wallentin L, Goldstein P, Granger CB, Bogaerts K, Danays T, et al. Meta-analysis of the efficacy and safety of unfractionated heparin versus enoxaparin in conjunction with tenecteplase for ST elevation myocardial infarction: Insights from ASSENT 3 and ASSENT 3 PLUS. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2003. p. 580–1.
Armstrong, P. W., et al. “Meta-analysis of the efficacy and safety of unfractionated heparin versus enoxaparin in conjunction with tenecteplase for ST elevation myocardial infarction: Insights from ASSENT 3 and ASSENT 3 PLUS.” CIRCULATION, vol. 108, no. 17, LIPPINCOTT WILLIAMS & WILKINS, 2003, pp. 580–81.
Armstrong PW, Wallentin L, Goldstein P, Granger CB, Bogaerts K, Danays T, Van de Werf F. Meta-analysis of the efficacy and safety of unfractionated heparin versus enoxaparin in conjunction with tenecteplase for ST elevation myocardial infarction: Insights from ASSENT 3 and ASSENT 3 PLUS. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2003. p. 580–581.
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 28, 2003
Volume
108
Issue
17
Start / End Page
580 / 581
Location
ORLANDO, FLORIDA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
76th Annual Scientific Session of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology